Business · 17/01/2023Updated: 10/17/2026 · 1 min read
FDA Classifies Prognostic Test for Liver Disease Progression into Class II Special Controls
Summary
The FDA is classifying the prognostic test for assessing liver-related disease progression into Class II special controls, aiming to ensure the device's safety and effectiveness while enhancing patient access to innovative devices.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →